Series A Biotechnology Companies

Mytos is building a fully-automated cell manufacture platform for Pharma

Ryp Labs develops and commercializes technologies designed to reduce food waste.

Nova Pangaea Technologies is a cleantech company that has developed a sustainable technology called REFNOVA

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

Gero is a biotechnology company that provides therapeutics against chronic diseases.

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.

Pixelgen Technologies develops technologies for biomedical research and diagnostics.

Pow.bio provides a genetically engineered solution for fermentation scientists.

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

traceless materials is a circular bioeconomy startup offering a holistically sustainable alternative to conventional plastics & bioplastics

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.